Is Multiple System Atrophy (MSA) Hereditary or Genetic?
At a Glance
Multiple system atrophy (MSA) is overwhelmingly a sporadic disease, meaning it occurs randomly and is not passed down from parents to children. While extremely rare familial cases exist, the vast majority of patients with MSA do not need to worry about their children inheriting the condition.
Multiple system atrophy (MSA) is overwhelmingly considered a sporadic disease, which means it occurs randomly and is not passed down from parents to children [1][2]. If you have been diagnosed with MSA, there is currently no evidence to suggest that your children are at a heightened risk of developing the condition compared to the general population [1][2].
When patients are diagnosed with a severe neurodegenerative disease, it is completely natural to worry about the health and future of their family members. However, unlike certain other neurological conditions that have clear genetic links, MSA does not have a well-established hereditary cause [3][4]. Because MSA is not genetic, it is important to know that you did not do anything to trigger this disease; the exact cause simply remains a medical mystery [1].
What Does “Sporadic” Mean?
In medicine, a sporadic condition is one that happens by chance. It means there is no clear family history of the disease and no predictable pattern of inheritance [1]. Large-scale genetic studies, which scan the DNA of thousands of people, have generally failed to identify any common genetic mutations that directly cause MSA, though they have occasionally identified some minor risk factors [3].
MSA belongs to a group of diseases where a specific protein (called alpha-synuclein) builds up abnormally in the brain [5][6]. Because of this protein buildup, researchers often compare MSA to Parkinson’s disease [5]. While Parkinson’s disease has several known genetic forms that can be inherited, MSA is driven by different mechanisms that remain largely sporadic rather than hereditary [5][4].
Are There Any Exceptions?
While MSA is not considered hereditary, you may come across research discussing genetics and MSA. It is helpful to understand the context of these studies:
- Extremely Rare Familial Cases: There are a very small number of documented reports in medical literature where MSA has appeared in multiple members of the same family [7][8]. However, these cases are considered exceptionally rare and do not represent the typical presentation of the disease [1][8].
- The COQ2 Gene: Researchers have investigated certain genes, most notably the COQ2 gene, as a potential risk factor [4]. Variations in this gene have been linked to a slightly higher risk of developing MSA in specific populations, such as Japanese cohorts [9][10]. However, this connection has not been consistently found in other populations, and simply carrying this genetic variation does not mean a person will definitely develop the disease [11][4].
- MSA “Mimics”: Sometimes, other inherited diseases that cause clumsiness and poor coordination can be mistaken for MSA [12]. If you have a strong family history of movement disorders, your doctor may order genetic testing to rule out these “mimic” conditions [12][13]. You may also want to ask your neurologist about speaking with a genetic counselor.
The Bottom Line
For the vast majority of people with MSA, the disease is a random occurrence. You can be reassured that your diagnosis does not mean you will pass the condition on to your children [1][2].
Because the disease is sporadic, your children do not need to undergo genetic screening or preventative neurological monitoring for MSA [1]. If you are looking for a simple way to share this news with your family, you can tell them: “My doctors have assured me this disease occurs randomly, and you are not at risk.”
Common questions in this guide
Is multiple system atrophy passed down to children?
Are there any genetic tests for multiple system atrophy?
What does the COQ2 gene have to do with MSA?
Do I need to see a genetic counselor if I have MSA?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my specific symptoms and family history, is there any reason to suspect an MSA 'mimic' condition that would require genetic testing?
- 2.Are there any clinical trials or research registries for MSA that I could participate in to help researchers understand why this disease occurs?
- 3.Given my family history, is there any value in speaking with a genetic counselor to put my children's minds at ease?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models.
Marmion DJ, Peelaerts W, Kordower JH
Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(10)):1507-1527 doi:10.1007/s00702-021-02419-8.
PMID: 34613484 - 2
Epigallocatechin gallate in multiple system atrophy (PROMESA).
Jellinger KA
Annals of translational medicine 2019; (7(Suppl 8)):S278 doi:10.21037/atm.2019.11.141.
PMID: 32015997 - 3
Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.
Hopfner F, Tietz AK, Ruf VC, et al.
Movement disorders : official journal of the Movement Disorder Society 2022; (37(10)):2110-2121 doi:10.1002/mds.29164.
PMID: 35997131 - 4
Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms.
Stefanova N, Wenning GK
Nature reviews. Neuroscience 2023; (24(6)):334-346 doi:10.1038/s41583-023-00697-7.
PMID: 37085728 - 5
Progress in the treatment of Parkinson-Plus syndromes.
Olfati N, Shoeibi A, Litvan I
Parkinsonism & related disorders 2019; (59()):101-110 doi:10.1016/j.parkreldis.2018.10.006.
PMID: 30314846 - 6
An Update on Parkinson's Disease and its Neurodegenerative Counterparts.
Adam H, Gopinath SCB, Arshad MKM, et al.
Current medicinal chemistry 2024; (31(19)):2770-2787 doi:10.2174/0929867330666230403085733.
PMID: 37016529 - 7
Comorbid pathologies and their impact on multiple system atrophy: current view.
Jellinger KA
Journal of neural transmission (Vienna, Austria : 1996) 2026; (133(5)):823-830 doi:10.1007/s00702-025-02972-6.
PMID: 40522495 - 8
A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson's disease with dementia.
Fanciulli A, Leys F, Lehner F, et al.
Brain communications 2022; (4(4)):fcac175 doi:10.1093/braincomms/fcac175.
PMID: 35855480 - 9
New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy.
Sun Z, Ohta Y, Yamashita T, et al.
Neurology. Genetics 2016; (2(2)):e54 doi:10.1212/NXG.0000000000000054.
PMID: 27123473 - 10
The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy.
Nakamoto FK, Okamoto S, Mitsui J, et al.
Scientific reports 2018; (8(1)):14215 doi:10.1038/s41598-018-32573-1.
PMID: 30242188 - 11
Genetic mutation analysis of the COQ2 gene in Italian patients with multiple system atrophy.
Procopio R, Gagliardi M, Brighina L, et al.
Gene 2019; (716()):144037 doi:10.1016/j.gene.2019.144037.
PMID: 31398377 - 12
The Strange Case of the Multiple MRI Phenotypes of RFC1 Mutation.
Mascalchi M, Santorelli FM
Cerebellum (London, England) 2023; (22(3)):478-481 doi:10.1007/s12311-022-01401-8.
PMID: 35359253 - 13
Biallelic Intronic AAGGG Expansion of RFC1 is Related to Multiple System Atrophy.
Wan L, Chen Z, Wan N, et al.
Annals of neurology 2020; (88(6)):1132-1143 doi:10.1002/ana.25902.
PMID: 32939785
This page provides educational information about the genetics of multiple system atrophy. It is not intended as medical advice. Always discuss your diagnosis and family history with your neurologist or a genetic counselor.
Get notified when new evidence is published on Multiple system atrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.